Fate Therapeutics Wins $4M Grant to Advance NK Cancer Immunotherapy – Genetic Engineering & Biotechnology News
|
Fate Therapeutics Wins $4M Grant to Advance NK Cancer Immunotherapy
Genetic Engineering & Biotechnology News Fate Therapeutics said today it has won a $4 million California Institute for Regenerative Medicine (CIRM) grant toward advancing one of its off-the-shelf engineered natural killer (NK) cell cancer immunotherapies into a first-in-human clinical trial … Fate Therapeutics (FATE) Reports Receipt of CIRM Grant for Clinical Translation of FT516 Off-the-Shelf Engineered NK … Fate Therapeutics Announces Receipt of CIRM Grant for Clinical Translation of FT516 Off-the-Shelf Engineered NK … |
